Gary Ruot was the picture of health. A 17-year-old baseball player living in Florida. He had just started to drive, when just a few months later, his vision started to fade. First in his right eye.

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...

European drug regulators are reportedly reviewing research that links Novo Nordisk‘s blockbuster diabetes injection Ozempic to a rare eye disorder. After the release of two independent studies from ...

In vivo laser axotomy of a single subbasal fiber (SBF) in an adult mouse. The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in ...

New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how ...

BLOOM (TAMPA) – Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to progressive vision loss—often starting with difficulty ...

Shares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a phase I/II study evaluating its eye drop KB801 for the treatment of ...

LONDON — Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European Medicines Agency's ...

Scientists at Oregon Health & Science University's Casey Eye Institute and Baylor College of Medicine's Cullen Eye Institute published findings from a two-year Phase I clinical trial in the journal ...

The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in Elche and the Spanish National Research Council (CSIC), is participating ...